Article
MDR1 polymorphisms affect the outcome of Chinese multiple myeloma patients.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie - 1 Nov 2017
Xiao Zhengrui, Yin Guangli, Ni Ying, Qu Xiaoyan, Wu Hanxin, Lu Hua, Qian Sixuan, Chen Lijuan, Li Jianyong, Qiu Hairong, Miao Kourong
Abstract excerpt
OBJECTIVE: To illustrate the association of MDR1 (Multidrug Resistance 1) polymorphisms at loci 1236, 2677, 3435 and the prognosis of multiple myeloma (MM) in Jiangsu population. METHODS: A total of 129 MM patients were recruited from Jiangsu Province, China. The DNA was extracted from white blood cells (WBC) of peripheral blood and was amplified by polymerase chain reaction-allele specific primers (PCR-ASP)....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
